At the White House, the Health and Human Services secretary left the misleading impression that the FDA’s decision to revoke its emergency use authorization of hydroxychloroquine and chloroquine for COVID-19 “removes a potential barrier” and makes it easier to access the drugs. The FDA’s action does the opposite.
Issues: coronavirus
Facebook Post Repeats Flawed Claim on Wuhan Lab Funding
Pence’s False Claims About Trump’s Handling of Coronavirus
Ahead of Trump Rally, Republicans Spin COVID-19 Metrics
Unpacking WHO’s Asymptomatic COVID-19 Transmission Comments
At a June 8 press conference, a World Health Organization scientist confusingly suggested that asymptomatic transmission of the coronavirus is “very rare” — a statement that many scientists found problematic, and which some politicians and those on social media seized upon as evidence that certain public health measures were not necessary.
Colorado Vaccine Bill Includes Nonmedical Exemptions for Children
Trump’s False Claim on Tijuana Coronavirus Cases
China Didn’t Stop Virus ‘Cold’ Outside Wuhan
In remarks about SARS-CoV-2, President Trump wrongly said China “stopped it cold” from spreading from Wuhan to other parts of China “but they didn’t stop it cold from coming to the United States … and the rest of the world.” It did spread in China beyond Wuhan, but China also took extreme measures to slow the spread of the disease that the U.S. did not.